ACTA CYTOLOGICA

metrics 2024

Transforming Cytology into Clinical Practice

Introduction

ACTA CYTOLOGICA is a premier journal dedicated to the field of cytology, offering a platform for researchers, professionals, and students interested in the intricate study of cellular biology and its applications in the medical domain. Published by KARGER in Switzerland, the journal has been a vital resource since its inception in 1960 and is recognized for its rigorous peer-reviewed articles. With a notable impact factor reflecting its significance—ranked in the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, and Q3 in Histology for 2023—ACTA CYTOLOGICA continues to contribute valuable insights into cytological research and its implications for clinical practice. The journal maintains an annual focus on cutting-edge studies and reviews that enhance understanding and methodological advancements in cytology. Although it does not provide open access, it remains an essential read for those involved in histology and pathology, promising to keep them abreast of the latest findings and technological innovations in the field.

Metrics 2024

SCIMAGO Journal Rank0.56
Journal Impact Factor1.60
Journal Impact Factor (5 years)1.90
H-Index65
Journal IF Without Self1.60
Eigen Factor0.00
Normal Eigen Factor0.27
Influence0.46
Immediacy Index0.60
Cited Half Life11.90
Citing Half Life8.70
JCI0.52
Total Documents3161
WOS Total Citations2188
SCIMAGO Total Citations12128
SCIMAGO SELF Citations1374
Scopus Journal Rank0.56
Cites / Document (2 Years)1.61
Cites / Document (3 Years)1.87
Cites / Document (4 Years)2.20

Metrics History

Rank 2024

Scopus

Pathology and Forensic Medicine in Medicine
Rank #83/208
Percentile 60.10
Quartile Q2
Histology in Medicine
Rank #32/62
Percentile 48.39
Quartile Q3

IF (Web Of Science)

PATHOLOGY
Rank 53/88
Percentile 40.30
Quartile Q3

JCI (Web Of Science)

PATHOLOGY
Rank 58/88
Percentile 34.09
Quartile Q3

Quartile History

Similar Journals

CytoJournal

Advancing the Frontiers of Cytopathology and Forensic Medicine.
Publisher: SCIENTIFIC SCHOLAR LLCISSN: 0974-5963Frequency: 1 issue/year

CytoJournal is a leading open-access journal focused on the fields of pathology and forensic medicine, published by SCIENTIFIC SCHOLAR LLC. With its esteemed reputation, the journal has achieved a Q2 ranking in the 2023 Category Quartiles in its field, indicating its significant contribution and impact among its peers. Over its convergence from 2004 to 2024, CytoJournal has established itself as a pivotal platform for researchers, professionals, and students to disseminate and exchange pioneering research findings related to cytopathology and diagnostic techniques. With an emerging Scopus rank of #115 out of 208 in the field, the journal maintains a solid percentile ranking of 44th, underlining its importance in the scientific community. CytoJournal's commitment to facilitating open access ensures that critical insights and advancements in pathology and forensic medicine are easily accessible to those at the forefront of this essential area of study.

BMJ Evidence-Based Medicine

Fostering Excellence in Evidence-Based Medicine.
Publisher: BMJ PUBLISHING GROUPISSN: 2515-446XFrequency: 6 issues/year

BMJ Evidence-Based Medicine is a premier journal published by BMJ Publishing Group that focuses on the critical appraisal and application of scientific evidence in clinical practice. With its ISSN 2515-446X and E-ISSN 2515-4478, this impactful journal operates out of the United Kingdom and has established itself as a leading resource in the field of evidence-based medicine, reflected by its impressive Q1 ranking in the Medicine (miscellaneous) category and a significant 93rd percentile ranking amongst General Medicine titles on Scopus. Offering an essential platform for researchers, practitioners, and students alike, the journal disseminates high-quality research and reviews that significantly influence healthcare practices worldwide. The journal currently has access options available for readers through institutional subscriptions and individual licenses, making cutting-edge research easily accessible to those dedicated to advancing medical knowledge. With its commitment to evidence-based practice, BMJ Evidence-Based Medicine plays a crucial role in improving patient outcomes and informing clinical decisions.

JOURNAL OF CLINICAL PATHOLOGY

Innovating Pathology for Better Health Outcomes
Publisher: BMJ PUBLISHING GROUPISSN: 0021-9746Frequency: 12 issues/year

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

BRITISH JOURNAL OF RADIOLOGY

Shaping the Future of Imaging through Rigorous Research
Publisher: BRITISH INST RADIOLOGYISSN: 0007-1285Frequency: 12 issues/year

British Journal of Radiology is a leading peer-reviewed journal published by the British Institute of Radiology, dedicated to advancing the field of radiology, nuclear medicine, and imaging. With a prestigious history dating back to 1945, this journal is at the forefront of disseminating cutting-edge research and innovations that significantly impact clinical practice. Currently enjoying a Q1 ranking in the field of radiology and Q2 in general medicine for 2023, it is recognized for its rigorous standards and high-quality content, ranking #87 out of 333 in Scopus for specialties related to Medicine, Radiology, Nuclear Medicine, and Imaging, placing it in the 74th percentile. Researchers, professionals, and students are encouraged to engage with the latest findings and comprehensive reviews presented within its pages, which contribute not only to academic discourse but also to the evolution of practice in the wider medical community.

Current Radiology Reports

Elevating clinical practice through innovative radiology reports.
Publisher: SPRINGERNATUREISSN: Frequency: 12 issues/year

Current Radiology Reports is an esteemed journal published by SPRINGERNATURE, focusing on the dynamic field of radiology, nuclear medicine, and imaging. With a commitment to advancing knowledge and promoting innovative practices, this journal serves as a valuable resource for researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. Featuring an impressive impact factor and recognized as a Q3 journal within its category as of 2023, it highlights critical developments and comprehensive reviews that inform clinical practice and research methodologies. Although it operates under a subscription model, the journal provides a rich repository of peer-reviewed content, covering a wide range of topics from diagnostic imaging to therapeutic applications. With a publication span from 2013 to 2024, Current Radiology Reports continues to uphold its reputation as a leading publication critical for anyone involved in the radiology profession.

Diagnostic and Interventional Imaging

Exploring the Future of Radiology and Nuclear Medicine
Publisher: ELSEVIER MASSON, CORP OFFISSN: 2211-5684Frequency: 12 issues/year

Diagnostic and Interventional Imaging, published by Elsevier Masson, stands as a prominent journal in the fields of Radiology, Nuclear Medicine, and Imaging. With a significant impact factor and a reputation for high-quality research, this journal is dedicated to advancing the understanding and application of diagnostic and interventional imaging techniques. It has achieved an impressive Q1 ranking across multiple categories including Medicine (miscellaneous) and Radiological and Ultrasound Technology, demonstrating its esteemed position within the academic community. The journal features cutting-edge studies and reviews, reflecting the latest innovations and practices from 2012 to 2024. Researchers, healthcare professionals, and students alike can look forward to accessing valuable insights that drive forward the discipline and improve patient outcomes, as evidenced by its robust Scopus rankings placing it among the top journals in its domain.

CYTOPATHOLOGY

Transforming Cell Analysis into Clinical Solutions
Publisher: WILEYISSN: 0956-5507Frequency: 6 issues/year

CYTOPATHOLOGY is a pivotal journal published by WILEY, focusing on the dynamic field of cytopathology within the broader medical and pathological sciences. Founded in 1990, this journal has become a crucial resource for researchers, professionals, and students interested in the microscopic examination of cell samples for diagnostic purposes. With an ISSN of 0956-5507 and E-ISSN of 1365-2303, CYTOPATHOLOGY is indexed in Scopus, where it currently holds a rank of #113 in Pathology and Forensic Medicine and #43 in Histology, placing it in the Q3 quartile for multiple categories in 2023. The journal publishes original research, reviews, and clinical studies that advance the understanding and application of cytopathology and its significance in health care. Although not an Open Access journal, its commitment to providing high-quality research makes it an essential platform for disseminating knowledge in the field. Researchers and practitioners looking to stay at the forefront of cytopathology developments will find CYTOPATHOLOGY to be an invaluable resource.

INFECTIOUS DISEASES IN CLINICAL PRACTICE

Connecting academia and healthcare for impactful solutions.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1056-9103Frequency: 6 issues/year

INFECTIOUS DISEASES IN CLINICAL PRACTICE, published by Lippincott Williams & Wilkins, is a crucial resource in the field of infectious diseases and microbiology. With an ISSN of 1056-9103 and an E-ISSN of 1536-9943, this journal has been a platform for scholarly communication since its inception in 1992, now spanning over two decades of continuous publication. The journal primarily focuses on the latest research developments, case studies, and clinical practices relevant to infectious diseases, making it an indispensable tool for researchers, healthcare professionals, and students alike. Although it is currently categorized in the Q4 quartile for both Infectious Diseases and Medical Microbiology, it continues to strive for excellence and relevance in a rapidly evolving field. By facilitating open access to impactful articles (note: Open Access not applicable), the journal aims to enhance global understanding and management of infectious diseases, ensuring that practitioners are well-equipped to confront contemporary challenges in this critical area of public health. Situated in the United States at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, INFECTIOUS DISEASES IN CLINICAL PRACTICE plays an essential role in fostering academic discourse and advancing clinical knowledge.

CANCER CYTOPATHOLOGY

Unveiling Insights into Cancer Cell Behavior
Publisher: WILEYISSN: 1934-662XFrequency: 12 issues/year

Cancer Cytopathology, published by Wiley, is an esteemed journal that plays a pivotal role in the fields of Cancer Research and Oncology. With a focus on the microscopic examination and analysis of cancerous cells, this journal serves as a crucial platform for disseminating high-quality research aimed at improving diagnostic techniques and therapeutic strategies. The journal holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, emphasizing its influence and importance within the scientific community. Additionally, it is recognized in the top 76th percentile in Medicine - Oncology and the 63rd percentile in Cancer Research according to Scopus rankings. Operating from the United States, Cancer Cytopathology is dedicated to fostering cutting-edge research and exploration in cytopathology, providing essential insights into cancer progression and management. Researchers and practitioners alike will find this journal invaluable for staying on the forefront of advancements in cancer diagnostics.

Journal of Radiology Case Reports

Bridging Clinical Practice and Research One Case at a Time
Publisher: EDURADISSN: 1943-0922Frequency: 12 issues/year

The Journal of Radiology Case Reports is a pioneering open-access journal dedicated to the publication of original case reports in the field of radiology, providing a crucial platform for the dissemination of valuable clinical insights and advancements in diagnostic imaging. Published by EDURAD since 2008, this journal aims to bridge the gap between clinical practice and ongoing research by showcasing unique cases that can enhance diagnostic accuracy and patient care. With an ISSN of 1943-0922, the journal is committed to excellence, evidenced by its current ranking in the Scopus database, where it stands at position #253 among 333 titles in the field, corresponding to a 24th percentile. The journal is indexed in notable databases and features an HIndex reflective of its ongoing contribution to medical literature. Researchers, professionals, and students can access insightful articles covering diverse case scenarios, thus enriching their knowledge of medical laboratory technology and enhancing their expertise in radiology, nuclear medicine, and imaging. The journal not only provides a wide reach through its open access model but also encourages collaborative research efforts, fostering the rapid circulation of case-based knowledge essential to the evolving landscape of radiological science.